[HTML][HTML] Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

LM Frerichs, B Frerichs, P Petzsch, K Köhrer… - Frontiers in …, 2023 - frontiersin.org
Background Patients with muscle-invasive bladder cancer face a poor prognosis due to
rapid disease progression and chemoresistance. Thus, there is an urgent need for a new …

[HTML][HTML] Mitochondrial DNA affects the expression of nuclear genes involved in immune and stress responses in a breast cancer model

C Grasso, DA Eccles, S Boukalova, MS Fabre… - Frontiers in …, 2020 - frontiersin.org
Tumor cells without mitochondrial (mt) DNA (ρ0 cells) are auxotrophic for uridine, and their
growth is supported by pyruvate. While ATP synthesis in ρ0 cells relies on glycolysis, they …

Synergic effects and possible mechanism of emodin and stilbene glycosides on colorectal cancer

G Zhou, RF Xie, SN Li, SX Chen, YM Feng, N Xiang… - Phytomedicine, 2024 - Elsevier
Background Polygonum multiflorum (PM) is a core herb that enhances immunity. It can also
detoxify, reduce swelling, and intercept malaria. Its main components, emodin (EMD) and 2 …

[HTML][HTML] C1QBP regulates apoptosis of renal cell carcinoma via modulating xanthine dehydrogenase (XDH) mediated ROS generation

Y Wang, S Liu, S Tian, R Du, T Lin, X Xiao… - … Journal of Medical …, 2022 - ncbi.nlm.nih.gov
Background: Complement component 1 Q subcomponent binding protein (C1QBP) plays a
vital role in the progression and metabolism of cancer. Studies have shown that xanthine …

[HTML][HTML] PLAG exerts anti-metastatic effects by interfering with neutrophil elastase/PAR2/EGFR signaling in A549 lung cancer orthotopic model

GT Kim, KW Hahn, SY Yoon, KY Sohn, JW Kim - Cancers, 2020 - mdpi.com
The effectiveness of chemotherapy and radiotherapy to treat lung cancer is limited because
of highly metastatic nature. Novel strategies and drugs to attenuate metastatic activity are …

Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells

S Singh, AK Maurya, A Meena, N Mishra… - Biochimica et Biophysica …, 2023 - Elsevier
Background Triple-negative breast cancer (TNBC) accounts for 20% of breast cancer that
does not express HER2, progesterone and estrogen receptors. It is associated with a high …

[HTML][HTML] Identification of key genes affecting the tumor microenvironment and prognosis of triple-negative breast cancer

J Yi, W Zhong, H Wu, J Feng, X Zouxu, X Huang… - Frontiers in …, 2021 - frontiersin.org
Although the tumor microenvironment (TME) plays an important role in the development of
many cancers, its roles in breast cancer, especially triple-negative breast cancer (TNBC) …

[HTML][HTML] A Holistic Approach to Hard-to-Treat Cancers: The Future of Immunotherapy for Glioblastoma, Triple Negative Breast Cancer, and Advanced Prostate Cancer

C Puig-Saenz, JRD Pearson, JE Thomas, SEB McArdle - Biomedicines, 2023 - mdpi.com
Immunotherapy represents an attractive avenue for cancer therapy due to its tumour
specificity and relatively low frequency of adverse effects compared to other treatment …

A new model applied for evaluating a rhenium-diselenium drug: Breast cancer cells stimulated by cytokines induced from polynuclear cells by LPS

V Veena, A Harikrishnan, B Lakshmi… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: New anticancer drugs are usually tested on cancer cells in culture in a
standard medium. We stimulated immune polynuclear cells by lipopolysaccharides to obtain …

Novel therapeutic approaches of ion channels and transporters in cancer

A Ramírez, J García-Quiroz, L Aguilar-Eslava… - Targets of Cancer …, 2020 - Springer
The expression and function of many ion channels and transporters in cancer cells display
major differences in comparison to those from healthy cells. These differences provide the …